- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 31.08. | ESC26: Heart attack reclassification rights gender imbalance | ||
| 28.08. | ESC26: Isomab safety evidence on blood vessel growth for CAD | ||
| 28.08. | Roivant wins FDA approval for first targeted dermatomyositis treatment | ||
| 28.08. | Anthropic AI tool conducts physical scientific experiments | ||
| 28.08. | FDA approves new COVID shots - with same restrictions as last year | ||
| 27.08. | Sword Health buys Headspace in $200M to $300M deal | ||
| 27.08. | ViiV wins US approval for HIV treatment in newborn babies | ||
| 27.08. | AZ, Amgen positive Ph3 results for Tezspire in EoE | ||
| 27.08. | Cyberattack on Boston Scientific causes global ops disruption | ||
| 26.08. | As drug costs for US employers rise, some cut GLP-1s from plans | ||
| 26.08. | Revolution's ASCO showstopper gets FDA greenlight | ||
| 26.08. | Spyre deprioritises arthritis drug after Phase 2 results | ||
| 26.08. | Jazz secures FDA approval for Ziihera in first-line HER2-positive GEA | ||
| 26.08. | Entropy, UCSF Pre-CTA for Ph2 psilocin vs Lexapro in MDD | ||
| 26.08. | Neurocrine receives FDA IND Acceptance for Alzheimer's Ph2 | ||
| 25.08. | FDA issues novel nods for diabetes monitor, migraine lenses | ||
| 25.08. | Expanded US Imaavy approval first ever for wAIHA | ||
| 25.08. | Lundbeck taps EVERSANA's AI Agency for commercialisation | ||
| 25.08. | Final judgement favours TwinStrand in Guardant patent case | ||
| 25.08. | FDA greenlights Roche's biomarker blood test for Alzheimer's | ||
| 24.08. | Trodelvy gets EU nod for first-line triple-neg breast cancer | ||
| 24.08. | Roche's Genentech strikes $2.3bn deal for Hanmi obesity drug HM17321 | ||
| 24.08. | EC greenlights Acadia's DAYBU for Rett Syndrome in Europe | ||
| 24.08. | Japan first approval for GSK's bepirovirsen for CHB | ||
| 21.08. | J&J scores EU approval for Tecvayli combo in second line |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.